Key Inclusion Criteria:~Male or female subject with a clinical diagnosis of Alzheimer's disease (AD), dementia
with Lewy bodies (DLB), or Parkinson's disease dementia (PDD).~Mini Mental State Examination score 14 to 26
Gait impairment, as assessed by history gathered by the clinical investigator and quantitative measurements
Subjects must be on stable background acetylcholinesterase inhibitor therapy~Key
